Log In
BCIQ
Print this Print this
 

RQ-00000010

  Manage Alerts
Collapse Summary General Information
Company RaQualia Pharma Inc.
DescriptionSerotonin 5-HT4 partial agonist
Molecular Target Serotonin (5-HT4) receptor
Mechanism of ActionSerotonin (5-HT4) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationGastroesophageal reflux disease (GERD)
Indication DetailsTreat gastroesophageal reflux disease (GERD)
Regulatory Designation
PartnerCJ Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/01/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today